Search

everythinglearnresearchcommunity

for

Search:↓

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Higher CRHR1 levels in AA patients lead to increased inflammation.

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.

Interleukin 6 may help protect skin without causing inflammation.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

IL-1 promotes fat cell growth in skin, while WNT inhibits it and encourages scar formation.

Atopy and altered T cell functions contribute to Alopecia Areata.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

IL-1 receptor absence in mice leads to skin cysts and changes in immune response after UVB exposure.

Enhancing Tregs can protect against alopecia areata.

Abnormal ECM and immune cell interactions can cause skin diseases.

SPT6 prevents excessive skin inflammation by blocking a feedback loop.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Type I interferons play a key role in the development of various skin diseases.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Overexpressing the glucocorticoid receptor in mice leads to abnormal skin development and reduced inflammation.

Hairless mice are more vulnerable to Listeria infection, but gut microbiota can help reduce damage.

SCF and ET-1 together significantly increase skin pigmentation and melanin production.

Inhibiting IL-17 and IL-23 improves wound healing in obese, diabetic mice by promoting healing macrophages.

Alopecia areata involves unique activation of certain immune cells.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Engineered cytokines show promise for improving tissue healing and safety in regenerative medicine.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Th22 cells are essential for Tβ15-induced hair growth in mice.

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.